UnknownNot Applicable

Colonization of Skin by M. Luteus Q24 Probiotic

New Zealand20 participantsStarted 2023-10-02

Plain-language summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face from a serum format in healthy adults.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. In general good health 18 - 80 years of age.
. Practice good general body hygiene.

Exclusion criteria

. Have a history of autoimmune disease or are immunocompromised (have a weakened immune system).
. Are on concurrent antibiotic therapy or regular antibiotic use within the last 1 week.
. People with allergies or sensitivity to dairy.
. People with an open wound on the Blis Q24 application sites.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days

Timeframe: Time Frame: 30 days post intervention

Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days

Trial details

NCT IDNCT06137209

SponsorBLIS Technologies Limited

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-11-22

View on ClinicalTrials.gov More Microbial Colonization trials

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. In general good health 18 - 80 years of age.
. Practice good general body hygiene.

Exclusion criteria

. Have a history of autoimmune disease or are immunocompromised (have a weakened immune system).
. Are on concurrent antibiotic therapy or regular antibiotic use within the last 1 week.
. People with allergies or sensitivity to dairy.
. People with an open wound on the Blis Q24 application sites.

What they're measuring

Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days

Timeframe: Time Frame: 11 days post intervention

Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days

Timeframe: Time Frame: 30 days post intervention

Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days